drugset / Trial / NCT05634057
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
RandomizedParallel-groupDouble-blindTreatment
Summary
The study aimed to investigate the effectiveness of anisodamine hydrobromide combined with heparin in the treatment of patients with critical infection, in the hope that the therapy will provide alternatives to the treatment of patients with critical infection.
Timeline
- Start
- 2024-01-25
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anisodamine | Traditional medicine (herbal / TCM) | 2 mg/kg | — |
| Subject | Heparin | Other / unclassified | 3000 iu | Subcutaneous |
| Subject | Heparin | Other / unclassified | 6000 iu | Subcutaneous |